Pituitary Macroadenoma and Severe Hypothyroidism: The Link between Brain Imaging and Thyroid Function.


Journal

Case reports in pediatrics
ISSN: 2090-6803
Titre abrégé: Case Rep Pediatr
Pays: United States
ID NLM: 101581030

Informations de publication

Date de publication:
2021
Historique:
received: 16 05 2021
revised: 30 07 2021
accepted: 04 08 2021
entrez: 26 8 2021
pubmed: 27 8 2021
medline: 27 8 2021
Statut: epublish

Résumé

In case of primary hypothyroidism, reactive pituitary hyperplasia can manifest as pituitary (pseudo) macroadenoma. We report the case of a 12-year-old boy who was evaluated for impaired growth velocity and increased body weight. Because of low insulin-like growth factor 1 levels and poor response to the growth hormone stimulation test, brain magnetic resonance imaging was performed and a pituitary macroadenoma was found. Treatment with levothyroxine was started, and thyroid function was evaluated approximately every 40 days to titrate the dosage. After few months of therapy, the size of the macroadenoma decreased and growth hormone secretion normalized. The pituitary returned to normal size in approximately 5 years. The boy went through puberty spontaneously and reached a normal adult height. In a patient affected by primary hypothyroidism, reactive pituitary hyperplasia can cause growth hormone deficiency; however, growth hormone secretion usually normalizes after starting levothyroxine treatment. Pituitary macroadenoma can be difficult to distinguish from severe pituitary hyperplasia; however, pituitary macroadenomas are rare in childhood, and our clinical case underlines how the hormonal evaluation is essential to achieve a correct diagnosis and prevent unnecessary surgery in a context of pituitary mass.

Identifiants

pubmed: 34434587
doi: 10.1155/2021/2360855
pmc: PMC8382546
doi:

Types de publication

Case Reports

Langues

eng

Pagination

2360855

Informations de copyright

Copyright © 2021 Silvia Ciancia et al.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

Paediatr Drugs. 2017 Aug;19(4):291-301
pubmed: 28534114
Radiology. 1993 Apr;187(1):1-14
pubmed: 8451394
Childs Nerv Syst. 2008 Dec;24(12):1505-8
pubmed: 18690463
Endocr Pract. 2006 Jan-Feb;12(1):29-34
pubmed: 16524860
Horm Res Paediatr. 2014;81(3):145-55
pubmed: 24525527
Clin Endocrinol (Oxf). 2011 Mar;74(3):281-8
pubmed: 20455887
Int J Endocrinol. 2015;2015:283492
pubmed: 26421010
J Pediatr Endocrinol Metab. 2013;26(3-4):211-2
pubmed: 23457291
Indian J Endocrinol Metab. 2011 Sep;15 Suppl 3:S216-23
pubmed: 22029027
Pediatr Neurosurg. 1998 Apr;28(4):195-7
pubmed: 9732247
Br J Biomed Sci. 2011;68(4):208
pubmed: 22263436
Br J Neurosurg. 1999 Apr;13(2):138-42
pubmed: 10616581
Pediatr Radiol. 2009 Feb;39(2):164-7
pubmed: 18815780
Horm Res. 2005;63(2):61-4
pubmed: 15668525
Turk J Pediatr. 2009 Nov-Dec;51(6):624-30
pubmed: 20196402
Ital J Pediatr. 2011 Apr 07;37:15
pubmed: 21473748

Auteurs

Silvia Ciancia (S)

Department of Medical and Surgical Sciences of the Mothers, Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.

Silvia Cesari (S)

Family Pediatrician, Parma, Italy.

Barbara Predieri (B)

Department of Medical and Surgical Sciences of the Mothers, Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.

Sergio Bernasconi (S)

Microbiome Research Hub, University of Parma, Italy.

Lorenzo Iughetti (L)

Department of Medical and Surgical Sciences of the Mothers, Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.

Classifications MeSH